Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Turnstone Biologics Corp. - Common Stock (NQ: TSBX )

0.4891 +0.0336 (+7.38%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 139,481
Open 0.4555
Bid (Size) 0.4603 (13)
Ask (Size) 0.4747 (7)
Prev. Close 0.4555
Today's Range 0.4555 - 0.5000
52wk Range 0.4393 - 5.750
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
From Turnstone Biologics Corp.
Via GlobeNewswire
Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
-81.12%
-81.12%
1 Month
-28.08%
-28.08%
3 Month
-79.36%
-79.36%
6 Month
-81.33%
-81.33%
1 Year
-80.24%
-80.24%

More News

Read More
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
Via Benzinga
Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
Via Benzinga
Dow Surges Over 500 Points; US Retail Sales Rise In July
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Turnstone Biologics (TSBX) Stock Down 38% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024
Via InvestorPlace
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
From Turnstone Biologics Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024
Via InvestorPlace
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Appoints William Waddill to its Board of Directors
From Turnstone Biologics Corp.
Via GlobeNewswire
TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023
Via InvestorPlace
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
From Turnstone Biologics Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Turnstone Biologics to Participate in Upcoming Investor Conferences
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
From Turnstone Biologics Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.